|
The document is a final report on a 4-week capsule toxicity study of Ammonium Perfluorooctanoate (APFO) conducted on Cynomolgus monkeys by Covance Laboratories, sponsored by the APME Ad-Hoc APFO Toxicology Working Group, which adhered to EPA Good Laboratory Practice Standards with some exceptions.
|
2001 |
AR226-1052
|
2rpV743jBkn3km3N5B567xMN |
159 |
|
The document is a final report on a 26-week capsule toxicity study of Ammonium Perfluorooctanoate (APFO) conducted in Cynomolgus monkeys by Covance Laboratories, sponsored by 3M, which complies with EPA Good Laboratory Practice Standards except for certain determinations performed by the University of Dundee.
|
2001 |
AR226-1052
|
5kx8p9gNpX1x8dL3qM9oJ6r4D |
463 |
|
The document reports on a 26-week toxicity study of Ammonium Perfluorooctanoate (APFO) conducted by 3M Environmental Laboratory on Cynomolgus monkeys, detailing the presence and concentration of perfluorooctanoate in various biological samples, while noting some exceptions to Good Laboratory Practice compliance.
|
2001 |
AR226-1052
|
gDNjeo1gjopdaY612bB61LRqN |
411 |
|
The document is a correspondence from the Association of Plastics Manufacturers in Europe (APME) to the EPA, enclosing final reports on oral toxicity studies of ammonium perfluorooctanoate (APFO) in monkeys conducted by Covance Laboratories and analytical work by 3M, as part of the administrative record AR-226.
|
1928 |
AR226-1052
|
KJXYD3GnJqLa6R3xyzXODk57N |
2 |